![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 26, 2022 12:24:18 PM
Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
May 26, 2022 11:35 AM ETTyme Technologies, Inc. (TYME)
Summary
Tyme Technologies is a clinical-stage biopharma company trading at a large discount to net cash + marketable securities.
After the company discontinued the development of its primary compound, they have announced exploration of strategic alternatives.
Board seems to be leaning towards a sale of the company.
https://seekingalpha.com/article/4514673-tyme-technologies-net-net-biopharma-exploring-strategic-alternatives?mailingid=27848581&messageid=2800&serial=27848581.369&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=27848581.369
https://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=15845110-950-563034&type=sect&TabIndex=2&companyid=873303&ppu=%252fdefault.aspx%253fsym%253dTYME
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM